Acyloxy nitroso compounds hydrolyze to nitroxyl (HNO), a nitrogen monoxide with distinct chemistry and biology. Ultraviolet-visible spectroscopy and mass spectrometry show hydrolysis rate depends on pH and ester group structure with the observed rate being trifluoroacetate (3) > acetate (1) > pivalate (2). Under all conditions, 3 rapidly hydrolyzes to HNO. A combination of spectroscopic, kinetic, and product studies show that addition of thiols increases the decomposition rate of 1 and 2, leading to hydrolysis and HNO. Under conditions that favor thiolates, the thiolate directly reacts with the nitroso group, yielding oximes without HNO formation. Biologically, 3 behaves like Angeli's salt, demonstrating thiol-sensitive nitric oxide-mediated soluble guanylate cyclase-dependent vasorelaxation, suggesting HNO-mediated vasorelaxation. The slow HNO-donor 1 demonstrates weak thiol-insensitive vasorelaxation, indicating HNO release kinetics determine HNO bioavailability and activity. These results show that acyloxy nitroso compounds represent new HNO donors capable of vasorelaxation depending on HNO release kinetics.
Acyloxy nitroso compounds hydrolyze to n class="Chemical">nitroxyl (HNO), a nitrogen monoxide with distinct chemistry and biology. Ultraviolet-visible spectroscopy and mass spectrometry show hydrolysis rate depends on pH and ester group structure with the observed rate being trifluoroacetate (3) > acetate (1) > pivalate (2). Under all conditions, 3 rapidly hydrolyzes to HNO. A combination of spectroscopic, kinetic, and product studies show that addition of thiols increases the decomposition rate of 1 and 2, leading to hydrolysis and HNO. Under conditions that favor thiolates, the thiolate directly reacts with the nitroso group, yielding oximes without HNO formation. Biologically, 3 behaves like Angeli's salt, demonstrating thiol-sensitive nitric oxide-mediated soluble guanylate cyclase-dependent vasorelaxation, suggesting HNO-mediated vasorelaxation. The slow HNO-donor 1 demonstrates weak thiol-insensitive vasorelaxation, indicating HNO release kinetics determine HNO bioavailability and activity. These results show that acyloxy nitroso compounds represent new HNOdonors capable of vasorelaxation depending on HNO release kinetics.
Authors: C R White; T A Brock; L Y Chang; J Crapo; P Briscoe; D Ku; W A Bradley; S H Gianturco; J Gore; B A Freeman Journal: Proc Natl Acad Sci U S A Date: 1994-02-01 Impact factor: 11.205
Authors: Thomas W Miller; Melisa M Cherney; Andrea J Lee; Nestor E Francoleon; Patrick J Farmer; S Bruce King; Adrian J Hobbs; Katrina M Miranda; Judith N Burstyn; Jon M Fukuto Journal: J Biol Chem Date: 2009-06-15 Impact factor: 5.157
Authors: Ryan J Holland; Rika Paulisch; Zhao Cao; Larry K Keefer; Joseph E Saavedra; Sonia Donzelli Journal: Nitric Oxide Date: 2013-10-11 Impact factor: 4.427
Authors: Mazen Kurdi; Vidhya Sivakumaran; Roy J Duhé; Miguel A Aon; Nazareno Paolocci; George W Booz Journal: Int J Biochem Cell Biol Date: 2012-08-22 Impact factor: 5.085
Authors: Landon Bellavia; Jenna F DuMond; Andreas Perlegas; S Bruce King; Daniel B Kim-Shapiro Journal: Nitric Oxide Date: 2013-03-30 Impact factor: 4.427
Authors: Sonia Donzelli; Gerry Fischer; Bruce S King; Christin Niemann; Jenna F DuMond; Jörg Heeren; Hartwig Wieboldt; Stephan Baldus; Christian Gerloff; Thomas Eschenhagen; Lucie Carrier; Rainer H Böger; Michael Graham Espey Journal: J Pharmacol Exp Ther Date: 2012-12-04 Impact factor: 4.030
Authors: Heba A H Mohamed; Mohamed Abdel-Aziz; Gamal El-Din A A Abuo-Rahma; S Bruce King Journal: Bioorg Med Chem Date: 2015-04-16 Impact factor: 3.641
Authors: Susan Mitroka; Mai E Shoman; Jenna F DuMond; Landon Bellavia; Omar M Aly; Mohamed Abdel-Aziz; Daniel B Kim-Shapiro; S Bruce King Journal: J Med Chem Date: 2013-08-26 Impact factor: 7.446